The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for International Finance Corporation
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
International Finance Corporation (IFC), a global development finance institution, acquired 1,89,62,247 equity shares (11.99% of share capital) of Artemis Medicare Services on November 15, 2025, through the conversion of 33,000 compulsorily convertible debentures (CCDs) at a pre-agreed price of INR 174.03 per share. The CCDs had been allotted to IFC in May 2024 under a Subscription Agreement dated April 5, 2024, and matured/were converted as scheduled. Separately, 4,11,59,625 shares (26.02% of share capital) held by promoter entity Constructive Finance Private Limited (CFPL) remain encumbered in IFC's favour under a non-disposal undertaking tied to a Share Retention Agreement, requiring promoters to maintain at least 26% voting interest. The total share capital of the company rose from INR 13.92 crore to INR 15.82 crore because of the conversion.
This signals strong long-term institutional commitment from a high-profile global investor and brings a credible foreign stakeholder onto the cap table, generally positive for sentiment. Promoter stability is reinforced via the retention lock-in, though the encumbrance on a large block of promoter shares is a structural overhang retail investors should be aware of.